dimethylmyleran has been researched along with busulfan in 22 studies
*Busulfan: An alkylating agent having a selective immunosuppressive effect on BONE MARROW. It has been used in the palliative treatment of chronic myeloid leukemia (MYELOID LEUKEMIA, CHRONIC), but although symptomatic relief is provided, no permanent remission is brought about. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), busulfan is listed as a known carcinogen. [MeSH]
*Busulfan: An alkylating agent having a selective immunosuppressive effect on BONE MARROW. It has been used in the palliative treatment of chronic myeloid leukemia (MYELOID LEUKEMIA, CHRONIC), but although symptomatic relief is provided, no permanent remission is brought about. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), busulfan is listed as a known carcinogen. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 17 (77.27) | 18.7374 |
| 1990's | 5 (22.73) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cobbold, SP; Leong, LY; Qin, S; Waldmann, H | 1 |
| DeGregorio, MW; Rappeport, JM; Smith, BR; Wiebe, VJ | 1 |
| Gengozian, N; Good, RA; Ishii, E | 1 |
| Lapidot, T; Reisner, Y; Salomon, O; Singer, TS; Terenzi, A | 1 |
| Deeg, HJ; Luk, K; Shulman, HM; Shuman, WB; Storb, R | 1 |
| Amos, D; Appelbaum, FR; Buckner, CD; Clift, RA; Doney, KC; Fefer, A; Hill, RS; Kanfer, EJ; Shulman, HM; Storb, R | 1 |
| Appelbaum, FR; Buckner, CD; Clift, RA; Doney, KC; Hill, RS; Kanfer, EJ; Petersen, FB; Shulman, HM; Stewart, P; Storb, R | 1 |
| Floersheim, GL; Torhorst, J | 2 |
| van Bekkum, DW | 1 |
| Floersheim, GL | 3 |
| Blackett, NM; Standen, GR | 1 |
| Hemsworth, BN | 1 |
| Abkowitz, JL; Guttorp, P; Linenberger, ML; Newton, MA; Persik, M | 1 |
| Boog, CJ; de Vries-van der Zwan, A; de Waal, LP; van der Pol, MA | 1 |
| Blackett, NM; Twentyman, PR | 1 |
| BIERMAN, HR; KELLY, KH; KNUDSON, AG; MAEKAWA, T; TIMMIS, GM | 1 |
| ALEXANDER, P; MIKULSKI, ZB | 1 |
| ELSON, LA; FLOERSHEIM, GL | 1 |
| CLIFFORD, P; CLIFT, RA; KHAN, AG; TIMMIS, GM | 1 |
2 review(s) available for dimethylmyleran and busulfan
| Article | Year |
|---|---|
Pharmacology of agents used in bone marrow transplant conditioning regimens.
Topics: Antineoplastic Agents; Bone Marrow Transplantation; Busulfan; Carmustine; Hematopoiesis; Humans; Immunosuppressive Agents; Melphalan; Whole-Body Irradiation | 1992 |
Conditioning regimens for marrow grafting.
Topics: Animals; Antilymphocyte Serum; Bone Marrow Transplantation; Busulfan; Cyclophosphamide; Cyclosporins; Graft Enhancement, Immunologic; Graft Rejection; Graft vs Host Disease; Histocompatibility; Host vs Graft Reaction; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Lymphocytes; Whole-Body Irradiation | 1984 |
20 other study(ies) available for dimethylmyleran and busulfan
| Article | Year |
|---|---|
Classical transplantation tolerance in the adult: the interaction between myeloablation and immunosuppression.
Topics: Animals; Antibodies, Monoclonal; Bone Marrow; Bone Marrow Transplantation; Busulfan; CD4 Antigens; CD8 Antigens; Chimera; Female; Immune Tolerance; Male; Mice; Mice, Inbred Strains; Skin Transplantation; Transplantation Immunology | 1992 |
Influence of dimethyl myleran on tolerance induction and immune function in major histocompatibility complex-haploidentical murine bone-marrow transplantation.
Topics: Animals; Antibody Formation; Bone Marrow Transplantation; Busulfan; Cytotoxicity, Immunologic; Immune Tolerance; Immunity, Cellular; Lymphocyte Culture Test, Mixed; Major Histocompatibility Complex; Mice; Mice, Inbred Strains; Radiation Chimera | 1991 |
Enhancement by dimethyl myleran of donor type chimerism in murine recipients of bone marrow allografts.
Topics: Animals; Bone Marrow Transplantation; Busulfan; Female; Graft Rejection; Hematopoiesis; Immunization; Lectins; Leukocyte Count; Mice; Mice, Inbred C3H; Mice, Inbred C57BL; Peanut Agglutinin; Preoperative Care; Radiation Chimera; Spleen; T-Lymphocytes; Tissue Donors; Whole-Body Irradiation | 1989 |
Induction of hepatic veno-occlusive disease in dogs.
Topics: Animals; Busulfan; Buthionine Sulfoximine; Cyclophosphamide; Disease Models, Animal; Dog Diseases; Dogs; Hepatic Veno-Occlusive Disease; Liver; Melphalan; Methionine Sulfoximine; Methotrexate; Monocrotaline; Pyrrolizidine Alkaloids; Radiation Injuries, Experimental; Radiography | 1987 |
Allogeneic and syngeneic marrow transplantation following high dose dimethylbusulfan, cyclophosphamide and total body irradiation.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Busulfan; Child; Child, Preschool; Cyclophosphamide; Drug Administration Schedule; Hepatic Veno-Occlusive Disease; Humans; Infant; Leukemia; Middle Aged; Premedication; Pulmonary Fibrosis; Transplantation, Homologous; Transplantation, Isogeneic; Whole-Body Irradiation | 1987 |
Phase I study of high-dose dimethylbusulfan followed by autologous bone marrow transplantation in patients with advanced malignancy.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Busulfan; Child; Combined Modality Therapy; Drug Evaluation; Female; Humans; Male; Middle Aged; Neoplasms | 1987 |
Inhibition by lymph node cells and promotion by fetal hepatocytes of murine tumours without or with chemotherapy.
Topics: Ancitabine; Animals; Antineoplastic Agents; Busulfan; Carcinogens; Cyclophosphamide; Female; Killer Cells, Natural; Leukemia, Experimental; Liver; Mice; Mice, Inbred BALB C; Mice, Inbred CBA; Moloney murine leukemia virus; Neoplasms, Experimental; Sarcoma, Experimental | 1981 |
Decreased tolerance to dimethyl-myleran, cyclophosphamide and radiation in lymphoma-bearing mice.
Topics: Animals; Bone Marrow Transplantation; Busulfan; Colony-Forming Units Assay; Cyclophosphamide; Dose-Response Relationship, Drug; Drug Tolerance; Female; Humans; Lethal Dose 50; Lymphoma; Male; Mice; Mice, Inbred C3H; Mice, Inbred CBA; Neoplasm Transplantation; Neoplasms, Experimental; Radiation Tolerance; Whole-Body Irradiation | 1982 |
Effect of daily administration of cytotoxic drugs on the erythroid and granulocytic repopulating ability of rat bone marrow.
Topics: Animals; Antineoplastic Agents; Busulfan; Cell Division; Cyclophosphamide; Erythrocytes; Granulocytes; Hematopoietic Stem Cells; Male; Rats; Time Factors | 1980 |
Control of a human tumour (Ewing sarcoma) in mice by a single lethal dose of dimethyl-myleran and bone marrow.
Topics: Animals; Bone Marrow Transplantation; Busulfan; Dose-Response Relationship, Drug; Humans; Immunosuppression Therapy; Male; Mice; Mice, Inbred C3H; Mice, Nude; Neoplasm Transplantation; Sarcoma, Ewing | 1981 |
Treatment of murine tumors with lethal doses of dimethylmyleran and autologous bone marrow.
Topics: Animals; Bone Marrow Transplantation; Busulfan; Female; Leukemia, Experimental; Mice; Mice, Inbred BALB C; Mice, Inbred CBA; Neoplasm Transplantation; Sarcoma, Experimental; Spleen; Transplantation, Autologous; Transplantation, Isogeneic | 1981 |
Comparative effect of the isomers of dimethylmyleran on spermatogenesis in the rat.
Topics: Animals; Busulfan; Male; Rats; Rats, Inbred Strains; Spermatogenesis; Stereoisomerism; Testis; Time Factors | 1981 |
Behavior of feline hematopoietic stem cells years after busulfan exposure.
Topics: Animals; Bone Marrow Cells; Busulfan; Cats; Cells, Cultured; Clone Cells; Female; Glucosephosphate Dehydrogenase; Hematopoiesis; Hematopoietic Stem Cells; Phenotype; Probability; Stochastic Processes; Time Factors | 1993 |
An alternative conditioning regimen for induction of specific skin graft tolerance across full major histocompatibility complex barriers.
Topics: Animals; Busulfan; Cyclophosphamide; Female; H-2 Antigens; Immune Tolerance; Immunosuppressive Agents; Male; Mice; Mice, Inbred C57BL; Skin Transplantation; Survivors; Transplantation Conditioning; Transplantation, Homologous | 1998 |
Action of cytotoxic agents on the erythroid system of the mouse.
Topics: Animals; Antineoplastic Agents; Busulfan; Cell Division; Dactinomycin; Dose-Response Relationship, Drug; Erythrocytes; Gamma Rays; Methotrexate; Mice; Mice, Inbred C57BL; Nucleic Acid Synthesis Inhibitors; Vinblastine | 1970 |
The influence of 1, 4-dimethylsulfonoxy-1, 4-dimethylbutane (CB 2348, dimethyl myleran) in neoplastic disease.
Topics: Busulfan; Leadership; Neoplasms | 1958 |
Differences in the response of leukaemia cells in tissue culture to nitrogen mustard and to dimethyl myleran.
Topics: Animals; Busulfan; Leukemia, Experimental; Mechlorethamine; Nitrogen Mustard Compounds; Research Design | 1961 |
[Bone marrow transplantation after dimethyl myleran as a method of evaluation of the effect of mutagenetic influences on transplantation antigenicity of hematopoietic cells].
Topics: Bone Marrow; Bone Marrow Transplantation; Busulfan; Histocompatibility Antigens; Transplantation Immunology | 1961 |
[Restoration of hematopoiesis following a lethal dose of dimethyl myleran by isologic bone marrow transplantation in mice. Experiments on modification of intolerance to homologous bone marrow by 6-mercaptopurine, aminochlorambucil and cortisone].
Topics: Animals; Bone Marrow; Bone Marrow Transplantation; Busulfan; Chlorambucil; Cortisone; Hematopoiesis; Hematopoietic System; Mechlorethamine; Mercaptopurine; Mice; Nitrogen Mustard Compounds | 1961 |
DIMETHYL MYLERAN THERAPY COMBINED WITH ABDOMINAL AORTIC OCCLUSION.
Topics: Adolescent; Alopecia; Aorta; Aorta, Abdominal; Busulfan; Chemotherapy, Cancer, Regional Perfusion; Diarrhea; Eye Manifestations; Facial Neoplasms; Head and Neck Neoplasms; Keratosis; Neoplasms; Skull Neoplasms; Stomatitis; Thrombocytopenia; Toxicology; Vomiting | 1964 |